Netherlands· NL-7ed800aee8c6
Neuraceq 300 MBq/mL, oplossing voor injectie
A florbetaben (18f) product containing florbetaben (18f), registered in Netherlands by Life Molecular Imaging GmbH. The same ATC class is registered in 11 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Florbetaben (18f) is registered in 11 of 19 countries.
Countries holding a registration under ATC V09AX06 (florbetaben (18f)), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 7 of them publish a price we can compare per daily dose
Florbetaben (18f) · ATC V09AX06
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Polandprice
- Switzerlandprice
- United Statesprice
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- FLORBETABEN (18F)
- Manufacturer
- Life Molecular Imaging GmbH
- Country
- Netherlands (NL)
- ATC code
- V09AX06
- ATC class
- Florbetaben (18F)
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_idEU/1/13/906
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Florbetaben (18f) in 8 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesNeuraceqLantheus Biosciences Ltd.
- CanadaNEURACEQISOLOGIC INNOVATIVE RADIOPHARMACEUTICALS LTD.
- CzechiaNEURACEQLantheus Germany GmbH, Berlín
- SpainNEURACEQ 300 MBq/ml solucion inyectableLantheus Germany Gmbh
- BelgiumNeuraceq 300 MBq/mlLantheus Germany
- United KingdomNeuraceq [F-18] 300MBq solution for injection vialsLantheus Biosciences Ltd
- SwedenNeuraceq 300 MBq/ml Injektionsvätska, lösningLantheus Germany GmbH
- FinlandNeuraceqLantheus Germany GmbH
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Neuraceq
- Liechtenstein · Neuraceq
- Norway · Neuraceq
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/34eea803-6d21-4d9b-89e0-0eb0b7c8809f GET /v1/drugs/34eea803-6d21-4d9b-89e0-0eb0b7c8809f?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Oplossing voor injectie",
"route": "Intraveneus gebruik",
"soort": null,
"source": "cbg_meb",
"smpc_url": "https://www.ema.europa.eu/en/documents/product-information/neuraceq-epar-product-information_nl.pdf",
"strength": null,
"atc_label": "Florbetaben (18F)",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp113350",
"excipients": [
"ASCORBINEZUUR (E 300)",
"ETHANOL",
"MACROGOL 400",
"NATRIUMASCORBAAT (E 301)",
"WATER VOOR INJECTIE"
],
"substances": [
"FLORBETABEN (18F)"
],
"leaflet_url": null,
"authorised_at": "2014/02/20",
"procedure_number": "EMEA/H/C/002553",
"dispensing_status": "Uitsluitend recept",
"registration_number": "EU/1/13/906",
"additional_monitoring": "N"
}See everything about florbetaben (18f).
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.